Jeff Yass’s PaxMedica, Inc. Common Stock PXMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-26,091
Closed -$13.3K 13606
2024
Q1
$13.3K Buy
+26,091
New +$15.3K ﹤0.01% 11881
2023
Q4
Sell
-1,826
Closed -$9.22K 13711
2023
Q3
$9.22K Buy
+1,826
New +$17.7K ﹤0.01% 11728
2023
Q2
Sell
-805
Closed -$26.1K 13550
2023
Q1
$26.1K Buy
+805
New +$32.3K ﹤0.01% 11964

Other funds holding PXMD

Jeff Yass's PXMD Position: Q2 2024 in Review

Jeff Yass sold out of PaxMedica, Inc. Common Stock (PXMD) in Q2 2024, closing a stake of 26,091 shares — an estimated $13.3K sold.

Jeff Yass first reported a position in PXMD in Q1 2023 and held it in 3 quarters. The position peaked at $26.1K in Q1 2023. 1 fund tracked by Wall St. Rank holds PXMD as of Q2 2024.

  • Jeff Yass reported no remaining PaxMedica, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Jeff Yass sold 26,091 PaxMedica, Inc. Common Stock shares in Q2 2024, an estimated $13.3K.
  • Jeff Yass first reported a position in PaxMedica, Inc. Common Stock in Q1 2023 and held it in 3 quarters.
  • Jeff Yass's PaxMedica, Inc. Common Stock position peaked at $26.1K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held PaxMedica, Inc. Common Stock as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.